ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.608
-0.44%
Brent Oil
83.745
0.65%
Bitcoin
66,903.07
2.55%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Protagenic Therapeutics Inc (PTIX)

  7. Protagenic Therapeutics Inc (PTIX) Noticias

PTIX

Protagenic Therapeutics (PTIX)

Protagenic Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PTIX
FechaHoraFuenteTítuloSímboloCompañía
14/02/202413:29Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PTIXProtagenic Therapeutics Inc
15/12/202314:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTIXProtagenic Therapeutics Inc
14/11/202315:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTIXProtagenic Therapeutics Inc
02/11/202315:29Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PTIXProtagenic Therapeutics Inc
13/10/202311:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTIXProtagenic Therapeutics Inc
17/04/202313:44Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:PTIXProtagenic Therapeutics Inc
22/03/202312:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIXProtagenic Therapeutics Inc
14/11/202213:20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTIXProtagenic Therapeutics Inc
12/10/202205:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTIXProtagenic Therapeutics Inc
08/03/202215:03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PTIXProtagenic Therapeutics Inc
15/02/202205:17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PTIXProtagenic Therapeutics Inc
04/02/202215:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTIXProtagenic Therapeutics Inc
23/11/202107:45TipRanksProtagenic Therapeutics (PTIX) Initiated with a Buy at Maxim GroupNASDAQ:PTIXProtagenic Therapeutics Inc
16/11/202108:58GlobeNewswire Inc.Protagenic Therapeutics Announces Third Quarter 2021 Results and Business UpdateNASDAQ:PTIXProtagenic Therapeutics Inc
10/09/202115:57Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:PTIXProtagenic Therapeutics Inc
30/08/202108:15GlobeNewswire Inc.Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ETNASDAQ:PTIXProtagenic Therapeutics Inc
17/08/202106:45GlobeNewswire Inc.Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business UpdateNASDAQ:PTIXProtagenic Therapeutics Inc
13/08/202116:29Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PTIXProtagenic Therapeutics Inc
23/07/202115:21GlobeNewswire Inc.Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical TrialNASDAQ:PTIXProtagenic Therapeutics Inc
06/07/202105:17GlobeNewswire Inc.Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 A...NASDAQ:PTIXProtagenic Therapeutics Inc
02/07/202115:48Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PTIXProtagenic Therapeutics Inc
16/06/202108:15GlobeNewswire Inc.Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17...NASDAQ:PTIXProtagenic Therapeutics Inc
03/06/202117:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIXProtagenic Therapeutics Inc
29/04/202114:06GlobeNewswire Inc.Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million Public Offering and Uplisting to NasdaqNASDAQ:PTIXProtagenic Therapeutics Inc
28/04/202116:30Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:PTIXProtagenic Therapeutics Inc
26/04/202119:58GlobeNewswire Inc.Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public OfferingNASDAQ:PTIXProtagenic Therapeutics Inc
13/02/201005:00PR Newswire (US)Performance Technologies Announces Rebranding of Company to PTNASDAQ:PTIX
12/02/201008:00PR Newswire (US)Performance Technologies Debuts NGN Xpress(TM) Product LineNASDAQ:PTIX
11/02/201007:00PR Newswire (US)Comfone Expands International Connectivity with Performance Technologies' SEGway(TM) Signalling SolutionNASDAQ:PTIX
27/01/201009:48PR Newswire (US)Performance Technologies Schedules Fourth Quarter 2009 Year End Earnings Release and Conference CallNASDAQ:PTIX
 Showing the most relevant articles for your search:NASDAQ:PTIX

Su Consulta Reciente

NASDAQ
ORRF
Orrstown Financial Servi...
HITB
ARCTUSD
ArbitrageCT
BIT
P1BAX1
BNP Paribas Issuance
BIT
UB5FXM
Unicredit Bank
COIN
CCOINETH
CREDITCOIN
NASDAQ
BLUD
LSE
SG25
Morg.st.b.v 26
LSE
75OR
Hsbc Bk. 23
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados